Annual EBIT
-$3.32 M
+$5.95 M+64.23%
September 30, 2024
Summary
- As of March 10, 2025, YCBD annual earnings before interest & taxes is -$3.32 million, with the most recent change of +$5.95 million (+64.23%) on September 30, 2024.
- During the last 3 years, YCBD annual EBIT has risen by +$20.95 million (+86.33%).
- YCBD annual EBIT is now -1033.65% below its all-time high of $355.10 thousand, reached on September 30, 2018.
Performance
YCBD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$86.30 K
-$286.70 K-143.06%
December 31, 2024
Summary
- As of March 10, 2025, YCBD quarterly earnings before interest & taxes is -$86.30 thousand, with the most recent change of -$286.70 thousand (-143.06%) on December 31, 2024.
- Over the past year, YCBD quarterly EBIT has stayed the same.
- YCBD quarterly EBIT is now -100.23% below its all-time high of $38.14 million, reached on September 30, 2022.
Performance
YCBD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$2.41 M
+$909.80 K+27.44%
December 31, 2024
Summary
- As of March 10, 2025, YCBD TTM earnings before interest & taxes is -$2.41 million, with the most recent change of +$909.80 thousand (+27.44%) on December 31, 2024.
- Over the past year, YCBD TTM EBIT has stayed the same.
- YCBD TTM EBIT is now -107.76% below its all-time high of $30.99 million, reached on June 30, 2023.
Performance
YCBD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
YCBD EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +64.2% | 0.0% | 0.0% |
3 y3 years | +86.3% | +93.5% | -314.4% |
5 y5 years | +76.9% | +93.5% | -314.4% |
YCBD EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +86.3% | -100.2% | +99.7% | -107.8% | +95.9% |
5 y | 5-year | at high | +86.3% | -100.2% | +99.7% | -107.8% | +95.9% |
alltime | all time | -1033.7% | +86.3% | -100.2% | +99.7% | -107.8% | +95.9% |
CbdMD EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | - | -$86.30 K(-143.1%) | -$2.41 M(-27.4%) |
Sep 2024 | -$3.32 M(-64.2%) | $200.40 K(-57.6%) | -$3.32 M(-42.1%) |
Jun 2024 | - | $472.50 K(-115.8%) | -$5.73 M(-28.1%) |
Mar 2024 | - | -$2.99 M(+200.4%) | -$7.97 M(+26.3%) |
Dec 2023 | - | -$996.10 K(-55.0%) | -$6.31 M(-32.6%) |
Sep 2023 | -$9.27 M(-46.5%) | -$2.21 M(+25.0%) | -$9.36 M(-130.2%) |
Jun 2023 | - | -$1.77 M(+32.5%) | $30.99 M(+2661.1%) |
Mar 2023 | - | -$1.33 M(-67.0%) | $1.12 M(-151.1%) |
Dec 2022 | - | -$4.05 M(-110.6%) | -$2.20 M(-87.3%) |
Sep 2022 | -$17.31 M(-28.6%) | $38.14 M(-220.6%) | -$17.31 M(-70.5%) |
Jun 2022 | - | -$31.63 M(+579.5%) | -$58.60 M(+131.4%) |
Mar 2022 | - | -$4.66 M(-75.7%) | -$25.32 M(-24.9%) |
Dec 2021 | - | -$19.16 M(+508.0%) | -$33.70 M(+38.9%) |
Sep 2021 | -$24.26 M(+38.0%) | -$3.15 M(-291.8%) | -$24.26 M(-5.4%) |
Jun 2021 | - | $1.64 M(-112.6%) | -$25.64 M(-10.4%) |
Mar 2021 | - | -$13.04 M(+34.2%) | -$28.62 M(+35.1%) |
Dec 2020 | - | -$9.72 M(+114.5%) | -$21.19 M(+20.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | -$17.58 M(+22.4%) | -$4.53 M(+238.8%) | -$17.58 M(-1.4%) |
Jun 2020 | - | -$1.34 M(-76.1%) | -$17.83 M(-22.3%) |
Mar 2020 | - | -$5.60 M(-8.4%) | -$22.95 M(+18.4%) |
Dec 2019 | - | -$6.11 M(+28.0%) | -$19.38 M(+35.0%) |
Sep 2019 | -$14.36 M(-4144.0%) | -$4.77 M(-26.2%) | -$14.36 M(+40.1%) |
Jun 2019 | - | -$6.47 M(+218.9%) | -$10.25 M(+224.8%) |
Mar 2019 | - | -$2.03 M(+85.7%) | -$3.16 M(-739.3%) |
Dec 2018 | - | -$1.09 M(+64.3%) | $493.70 K(+71.5%) |
Sep 2018 | $355.10 K(-141.3%) | -$664.40 K(-205.9%) | $287.80 K(-57.5%) |
Jun 2018 | - | $627.50 K(-61.3%) | $676.70 K(+577.4%) |
Mar 2018 | - | $1.62 M(-225.0%) | $99.90 K(-106.3%) |
Dec 2017 | - | -$1.30 M(+371.0%) | -$1.59 M(+85.3%) |
Sep 2017 | -$860.50 K(-77.0%) | -$275.50 K(-643.4%) | -$860.50 K(-46.7%) |
Jun 2017 | - | $50.70 K(-169.9%) | -$1.61 M(-47.7%) |
Mar 2017 | - | -$72.50 K(-87.1%) | -$3.09 M(+2.4%) |
Dec 2016 | - | -$563.20 K(-45.3%) | -$3.01 M(+23.0%) |
Sep 2016 | -$3.73 M | -$1.03 M(-27.6%) | -$2.45 M(+72.4%) |
Jun 2016 | - | -$1.42 M | -$1.42 M |
FAQ
- What is cbdMD annual earnings before interest & taxes?
- What is the all time high annual EBIT for cbdMD?
- What is cbdMD annual EBIT year-on-year change?
- What is cbdMD quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for cbdMD?
- What is cbdMD quarterly EBIT year-on-year change?
- What is cbdMD TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for cbdMD?
- What is cbdMD TTM EBIT year-on-year change?
What is cbdMD annual earnings before interest & taxes?
The current annual EBIT of YCBD is -$3.32 M
What is the all time high annual EBIT for cbdMD?
cbdMD all-time high annual earnings before interest & taxes is $355.10 K
What is cbdMD annual EBIT year-on-year change?
Over the past year, YCBD annual earnings before interest & taxes has changed by +$5.95 M (+64.23%)
What is cbdMD quarterly earnings before interest & taxes?
The current quarterly EBIT of YCBD is -$86.30 K
What is the all time high quarterly EBIT for cbdMD?
cbdMD all-time high quarterly earnings before interest & taxes is $38.14 M
What is cbdMD quarterly EBIT year-on-year change?
Over the past year, YCBD quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is cbdMD TTM earnings before interest & taxes?
The current TTM EBIT of YCBD is -$2.41 M
What is the all time high TTM EBIT for cbdMD?
cbdMD all-time high TTM earnings before interest & taxes is $30.99 M
What is cbdMD TTM EBIT year-on-year change?
Over the past year, YCBD TTM earnings before interest & taxes has changed by $0.00 (0.00%)